feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Business and Economy / Robots Drive Growth: Intuitive Surges Ahead

Robots Drive Growth: Intuitive Surges Ahead

1 Feb

•

Summary

  • Surgical robot placements increased by 532 units in Q4 2025.
  • Recurring revenue constitutes 75% of the company's income.
  • AI integration is a key future growth driver for surgical tools.
Robots Drive Growth: Intuitive Surges Ahead

Intuitive Surgical concluded 2025 with robust performance, reporting 532 da Vinci surgical robot placements in the fourth quarter, a notable increase from the prior year. The company now boasts over 11,106 operational systems globally, marking a 12% year-over-year rise.

While the placement of these advanced robotic systems is a key indicator, the core of Intuitive Surgical's revenue comes from supporting instruments and accessories, accounting for approximately 60% of sales. The actual sale of the da Vinci robots represents about 25% of revenue, with services making up the remaining 15%.

A significant strength lies in the recurring revenue model, which comprises about 75% of the company's income. This consistent income stream grows with each installed unit, as robots require ongoing maintenance and parts. The increasing utilization of these systems is crucial, evidenced by an 18% rise in procedures performed with da Vinci in 2025 compared to 2024.

trending

Ohio snow emergency declared

trending

TikTok down in United States

trending

Andreeva matches Venus Williams' feat

trending

Warrington Hospital baby death

trending

Alexander Zverev advances in Australia

trending

Oilers host Capitals

trending

London celebrates Chinese New Year

trending

Liza Minnelli defends AI use

Looking ahead, Intuitive Surgical is poised for further growth, with a projected surgery growth rate of up to 15% for 2026. Artificial intelligence represents a major opportunity, with the company actively integrating AI into its products. Recent FDA approval for an AI tool aiding lung biopsies in late 2025 highlights the potential for AI to enhance surgical precision, especially in dynamic environments. The company envisions AI playing an even more significant role in future surgical interventions.

Despite these strengths and future prospects, the company's valuation reflects investor confidence, with a price-to-earnings ratio nearing 67x, substantially higher than the S&P 500's 28x. This high valuation may deter investors with a strong preference for value stocks.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Intuitive Surgical ended 2025 strongly, placing 532 da Vinci surgical robots in the fourth quarter and increasing its global installed base by 12% year-over-year.
Approximately 60% of Intuitive Surgical's revenue comes from instruments and accessories, with 75% of its total income being recurring revenue from services and maintenance.
Intuitive Surgical is integrating AI into its products to assist surgeons, receiving FDA approval in late 2025 for an AI tool that enhances lung biopsies.

Read more news on

Business and Economyside-arrowArtificial Intelligence (AI)side-arrow

You may also like

Motional Reboots Robotaxis with AI-First Strategy

12 Jan • 116 reads

article image

Ozlo: From Sleepbuds to Wellness Platform

10 Jan • 132 reads

article image

Robot Surgeon Now Operates on Children in Europe

9 Jan • 110 reads

article image

AI Predicts Liposuction Blood Loss with 94% Accuracy

2 Jan • 156 reads

Revolutionary Wind Turbines Aim to Power AI's Energy Needs

1 Jan • 146 reads

article image